| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to newborn or infant testing for congenital |
|
|
cytomegalovirus. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. The heading to Section 47.003, Health and Safety |
|
|
Code, is amended to read as follows: |
|
|
Sec. 47.003. NEWBORN OR INFANT HEARING SCREENING, TRACKING, |
|
|
AND INTERVENTION PROGRAM; TESTING FOR CONGENITAL CYTOMEGALOVIRUS. |
|
|
SECTION 2. Section 47.003, Health and Safety Code, is |
|
|
amended by amending Subsections (a), (a-1), and (c) and adding |
|
|
Subsection (g) to read as follows: |
|
|
(a) A birthing facility, through a program certified by the |
|
|
department under Section 47.004, shall perform, either directly or |
|
|
through a referral to another program certified under that section, |
|
|
a hearing screening for the identification of hearing loss and a |
|
|
test for congenital cytomegalovirus on each newborn or infant born |
|
|
at the facility before the newborn or infant is discharged from the |
|
|
facility unless: |
|
|
(1) the parent declines the screening or test; |
|
|
(2) the newborn or infant is transferred to another |
|
|
facility before the screening or test is performed; |
|
|
(3) the screening or test has previously been |
|
|
completed; or |
|
|
(4) the newborn was discharged from the birthing |
|
|
facility not more than 10 hours after birth and a referral for the |
|
|
newborn was made to a program certified under Section 47.004 at |
|
|
another birthing facility or operated by a physician or other |
|
|
health care provider. |
|
|
(a-1) The birthing facility shall inform the parents during |
|
|
admission that: |
|
|
(1) the facility is required by law to: |
|
|
(A) screen a newborn or infant for hearing loss; |
|
|
and |
|
|
(B) conduct a test for congenital |
|
|
cytomegalovirus; and |
|
|
(2) the parents may decline both the screening and the |
|
|
test required under Subdivision (1). |
|
|
(c) Subject to Section 47.008, the department shall |
|
|
maintain data and information on each newborn or infant who |
|
|
receives a hearing screening or congenital cytomegalovirus test |
|
|
under Subsection (a). |
|
|
(g) In this section, "congenital cytomegalovirus" has the |
|
|
meaning assigned by Section 46.001. |
|
|
SECTION 3. This Act takes effect September 1, 2023. |